Cargando…
Inhaled activated protein C: a novel therapy for acute lung injury?
Acute lung injury (ALI) is characterized by the presence of dysregulated coagulation and inflammation. Therefore, Waerhaug and colleagues hypothesized that administration of activated protein C (APC) via the inhaled route would be a novel and effective treatment for ALI. They demonstrated that inhal...
Autores principales: | Liu, Kathleen D, Looney, Mark R, Matthay, Michael A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717421/ https://www.ncbi.nlm.nih.gov/pubmed/19519935 http://dx.doi.org/10.1186/cc7869 |
Ejemplares similares
-
Inhaled activated protein C: a new therapy for the prevention of ventilator-induced lung injury?
por: Abraham, Edward
Publicado: (2010) -
Bench-to-bedside review: The role of activated protein C in maintaining endothelial tight junction function and its relationship to organ injury
por: Looney, Mark R, et al.
Publicado: (2006) -
Protein C as a surrogate end-point for clinical trials of sepsis
por: Liu, Kathleen D, et al.
Publicado: (2008) -
Activated protein C inhalation: A novel therapeutic strategy for acute lung injury
por: Bo, Lulong, et al.
Publicado: (2011) -
Inhaled aptamer therapy: A hopeful therapy for lung disease
por: Martin, M. Elena
Publicado: (2023)